SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-060786
Filing Date
2019-12-16
Accepted
2019-12-16 21:32:37
Documents
2
Period of Report
2019-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1548
2 POA DOCUMENT poa.txt EX-24.3_883743 2300
  Complete submission text file 0001209191-19-060786.txt   5569
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1020 KIFER ROAD SUNNYVALE CA 94086
Business Address 1020 KIFER ROAD SUNNYVALE CA 94086 408-523-7587
Myriam Curet (Reporting) CIK: 0001632901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-24006 | Film No.: 191288479